NCT06136572 Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
| NCT ID | NCT06136572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Tourette Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-05-06 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2024-05-06 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).
Eligibility Criteria
Inclusion Criteria: * Tourette syndrome * Participants aged 18 years or over Exclusion Criteria: * Participants under legal protection * Inability to complete questionnaires alone
Contact & Investigator
Isabelle JALENQUES
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06136572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tourette Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06136572 currently recruiting?
Yes, NCT06136572 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06136572 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06136572 clinical trial?
NCT06136572 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Isabelle JALENQUES at University Hospital, Clermont-Ferrand. The trial plans to enroll 350 participants.